ClinicalTrials.Veeva

Menu

Treatment of Stress Urinary Incontinence by Injection of Autologous Muscle Fibers Into the Urethral Sphincter.

C

Copenhagen University Hospital at Herlev

Status and phase

Unknown
Phase 2
Phase 1

Conditions

Urinary Incontinence, Stress

Treatments

Procedure: Periurethral injection

Study type

Interventional

Funder types

Other

Identifiers

NCT01323426
H-1-2009-079 and H-1-2011-032

Details and patient eligibility

About

This pilot study examines safety and efficacy of a simple procedure for treatment of stress urinary incontinence. A muscle biopsy is taken from the thigh, minced and injected into the urethral sphincter.

Enrollment

40 estimated patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Stress urinary incontinence refractory to conservative treatment.

Exclusion criteria

  • urge urinary incontinence
  • Pregnancy
  • Pelvic organ prolapse > grade 1

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

40 participants in 1 patient group

periurethral injection
Experimental group
Description:
Periurethral injection of autologous muscle fibers
Treatment:
Procedure: Periurethral injection

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems